March 1, 2018
Philips launches AI platform for healthcare
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. Making their debut at the 2018 HIMSS Conference & Exhibition (HIMSS18), HealthSuite Insights gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry’s first ecosystem where curated Artificial Intelligence assets from Philips and others are readily available for license. AI-based solutions have great potential to improve patient outcomes and care efficiency. However, developing and deploying AI solutions for healthcare use cases can be time consuming, resource intensive and expensive. HealthSuite Insights eases the logistical challenges of deploying AI solutions in research and clinical environments. It accelerates the development of analytics solutions, and reduces development and total cost of AI solutions. “The quality of your AI is only as good as the quality of the data you feed into it,” said Jeroen Tas, Chief Innovation & Strategy Officer Philips. “We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers. With the HealthSuite Insights platform, we give them the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency.”
We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers.
Jeroen Tas
Chief Innovation & Strategy Officer Philips
Proven tools and technologies
The tools and technologies available through HealthSuite Insights already enable the machine learning and deep learning applications in Philips’ diagnostic imaging solutions, patient monitoring solutions, and oncology and genomics offerings. Enabled by the platform, Philips leverages AI across these innovations, by combining it with other technologies and a deep understanding of the clinical, operational and personal context to augment care professionals and patients/consumers.
Insights Marketplace for reusable AI assets
Philips’ Insights Marketplace initially offers assets supplied by Philips – including assets developed by leading scientists at Philips Research. Medically validated Philips assets will be added later this year. In late 2018, the Insights Marketplace will be further expanded to include assets submitted by third parties. AI assets built using the Insights Platform are designed to be secure regardless of the execution environment, with sophisticated Identity and Access Management, integrated Blockchain services, and data collection and management services built in. The Insights platform can be deployed on a healthcare cloud infrastructure such as the Philips HealthSuite Digital Platform, or on premise at a provider site. For more information on HealthSuite Insights and Philips’ full suite of integrated solutions for driving operational efficiency and improving clinical excellence, visit booth #3812 at the 2018 Annual HIMSS Conference & Exhibition taking place March 5 - 9 at the Sands Expo in Las Vegas, NV. For updates on Philips’ presence at HIMSS, follow @PhilipsLiveFrom and visit www.philips.com/himss.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
